SUMO2 and infection: These data demonstrate that ICP0 targets additional SUMO-modified proteins for degradation other than those constitutively modified at ND10, consistent with its ability to localize to SUMO-2/3 conjugates in PML-depleted cells during the initial stages of infection (Figure 2E).